Companies similar to UW ADRC
Sign up to Download

31-60 of 6,678,420 results

  • capmm.science.gmu.edu
  • 17
  • 1
  • 22
We are an academic research center within the College of Science, School of Systems Biology on the Prince William campus of George Mason University. Our biomedical research team consists of 15 scientists and 9 fellows from varied backgrounds and..

Relevance: 25.612997
  • ep-ad.org
  • 1
EPAD - the European Prevention of Alzheimer's Dementia Consortium - was an interdisciplinary research programme spanning public and private sector organisations across Europe, with 39 partners, ending October 2020... A key achievement of the EPAD..

Relevance: 25.509146
  • aibl.org.au
  • 1
  • 2
  • 11
AIBL discoveries have helped develop new drugs recently approved by the US FDA for slowing the worsening of Alzheimer's disease. Our study revealed the potential for very early treatment before symptoms develop, leading to current drug trials that..

Relevance: 25.455303
  • www.alzheimersresearchfoundation.com
Over the last thirty years most of the focus on Alzheimer's has been on pharmaceutical solutions for treating the symptoms, not on finding a cure. The Alzheimer's Research Foundation, unlike education or caregiver support organizations, is a 501c (3)..

Relevance: 25.43465
  • www.axon-neuroscience.eu
  • 4
  • 8
Axon Neuroscience was founded in 1999 by Professor Michal Novák, who began his research in the late 1980s in the Laboratory of Molecular Biology, MRC in Cambridge with Nobel Laureates Sir Aaron Klug, Cesar Milstein and John Walker. Professor Novak..

Relevance: 25.336912
  • www.villeneuvelab.com
  • 1
The Villeneuve Lab is interested in how the brain ages, with a specific focus on factors that modify the association between brain lesions and cognitive performance. Our research is motivated by the fact that more than 25% of older adults are..

Relevance: 25.14032
  • www.miklossy.ch
  • 1
Answering the questions, previously included in researcher's profile of Alzheimer Research Forum (www.alzforum.org) defines well the path we are following with respect to the pathogenesis of Alzheimer's disease and chronic/late Lyme disease. The same..

Relevance: 25.103811
  • enlightenimaging.com
  • 3
Our mission is to bring a retinal camera to detect Alzheimer's disease to the clinic and to facilitate clinical trials... Enlighten imaging is a startup company that span out from the Centre for Eye Research Australia (CERA) in 2018... We are the..

Relevance: 25.054304
  • globalalzplatform.org
  • 1
  • 30
million Americans are living with Alzheimer's disease, over 16 million Americans actively support their care... was the year the last therapy approved for modestly addressing Alzheimer's disease was developed. There are no disease-modifying..

Relevance: 25.040728
  • www.ocneuroscience.com
  • 1
  • 1
We provide clinical care and research services for patients with a variety of neurological disorders such as headaches, dementia/Alzheimer's Disease, and epilepsy...

Relevance: 25.000904
  • hussainilab.org
  • 1
Our aim is to understand the function of the brain in aging and in neurodegenerative diseases such as Alzheimer's disease. Read about our research...

Relevance: 24.967276
  • keystoneclinicalstudies.com
  • 6
  • 1
  • 5
KCS is a dedicated clinical trial site focused on finding new treatments for Alzheimer's disease and other psychiatric disorders by bridging the gap between science and clinical practice... At KCS, we conduct clinical trials for investigational..

Relevance: 24.874966
  • ai4ad.org
  • 2
  • 9
  • 32
Our team of experienced PIs will coordinate efforts across the U.S. to create these large-scale data analytic tools. Our MPI team and 6 Core Leads have decades of experience working together and with the AD community in pioneering machine learning..

Relevance: 24.859194
  • health.questdiagnostics.com
Leading the conversation around Alzheimer's research and the latest testing innovations... Hear from Dr Stephen Salloway and Dr Michael Racke as they discuss the current opportunities and challenges in diagnosing Alzheimer's Disease, the emerging..

Relevance: 24.838148
  • museslabs.com
  • 1
  • 1
With a team of doctors, scientists, technology experts, and seasoned entrepreneurs, Muses Labs is bringing to market a next-generation personalized combination therapy for Alzheimer's disease... The approach we're employing relies upon advanced..

Relevance: 24.823002
  • agingmindfoundation.org
  • 1
  • 20
The Aging Mind Foundation believes that in order to find the cause and cure for dementia and Alzheimer's disease, we must support high-quality brain research. That is why AMF is committed to giving grants to beneficiaries that are moving the needle..

Relevance: 24.76348
  • www.alzdiscovery.org
  • 2
  • 1
  • 68
The ADDF focuses on translating the knowledge we have gained about the causes of Alzheimer's disease - known as the "biology of aging" - into drugs to conquer it. We support diverse projects focused on novel targets that hold great promise, but also..

Relevance: 24.69919
  • karchlab.wustl.edu
  • 34
  • 1
  • 16
The goal of the Karch lab is to understand the molecular drivers of Alzheimer's disease, frontotemporal dementia, and other neurodegenerative disease. To do this, we use functional genomics along side stem cell and mouse models. The Karch lab has..

Relevance: 24.685377
  • eastonad.ucla.edu
  • 36
  • 26
  • 73
The Easton Center is committed to equity, diversity, inclusion, and belonging, in our research, care, and support of people, families, and communities living with Alzheimer's disease and related disorders... Our resource library comprises..

Relevance: 24.680939
  • durhamspatialsocial.wordpress.com
  • 1
Although our research examines the fundamental basics of these three areas, we have become increasingly focused upon how Alzheimer's disease neurodegeneration affects spatial cognition and social behaviour. We are currently running a NHS clinical..

Relevance: 24.67634
  • www.lloydtran.com
After the success of Artemether, Lloyd began doing research on neurodegenerative diseases when his father developed symptoms of Alzheimer's disease (AD). There are more than 6.5 million people in the US and 50 million people worldwide have this..

Relevance: 24.671518
  • columbusmemorycenter.com
  • 1
  • 1
Columbus Memory Center - Dementia treatment and research, Dementia, Research, Alzheimer's, Neurology, Neurologist, Dr. Jonathan Liss, Jonathan Liss M.D. Our Fight: Battling Alzheimer's by Preserving Independence Our Mission: Columbus Memory Center..

Relevance: 24.61946
  • www.alzspec.org
  • 1
  • 2
Alzheimer's Spectrum Foundation's goal is to raise awareness for the underrepresented groups of people dealing with Alzheimer's disease. These people have atypical rates of disease progression and exhibit a wide spectrum of symptoms. AlzSpec also..

Relevance: 24.558887
  • curealz.org
  • 1
  • 35
As a nonprofit organization whose purpose is to end a massive and terrible human condition, we are steadfastly focused on our mission. Our operational model is complex, our ecosystem of researchers is wide-ranging, and the problem we are obsessed..

Relevance: 24.532364
  • rajlab.org
  • 1
  • 1
The Raj Laboratory is dedicated to understanding the molecular mechanisms of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis... We are a member of the Ronald Loeb Center for..

Relevance: 24.510513
  • drivesproject.wustl.edu
  • 25
  • 1
  • 15
Welcome! Under the leadership and direction of Dr. Ganesh M. Babulal, the DRIVES Project is working to understand how preclinical Alzheimer's disease (AD) impacts driving behavior. Our main area of focus is to examine how older drivers with and..

Relevance: 24.468576
  • www.gv-971.com
  • 1
  • 1
GV-971 (Sodium Oligomannate) is a first-in-class new drug for the treatment of Alzheimer's disease (AD) successfully developed by the research team led by Professor Meiyu-Geng, Deputy Director of the Shanghai Institute of Materia Medica (SIMM),..

Relevance: 24.45106
  • branchlab.ku.edu
  • 4
  • 1
  • 3
Women and Alzheimer's Disease - We investigate ageing-related risk factors for Alzheimer's disease that disproportionately affect women. We are currently building a cohort of middle-aged participants to study sex differences in midlife risk factors..

Relevance: 24.25303
  • gismotherapeutics.com
  • 1
  • 1
  • 7
Gismo Therapeutics Inc. is a biotech start-up company targeting fundamental biochemical processes that are at the root cause of Alzheimer's and Parkinson's Disease pathogenesis. The company has been awarded several prestigious research grants to..

Relevance: 24.100498
  • www.atca.company
  • 1
  • 1
Our mission is simple - we treat Alzheimer's and only Alzheimer's with its related issues of memory loss, cognitive impairment and dementia. It is this singular focus that makes ATCA so extraordinary... Alzheimer's Treatment Centers of America..

Relevance: 24.015442